KV

Kuchipudi Vanaja

Active Director Director DIN 01030437
DIN 01030437 First appointment Apr 1996 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 2 historical roles
Total affiliations 8 Since Apr 1996
Shareholding value •••• Premium profile

About Kuchipudi Vanaja

Data last updated:

Kuchipudi Vanaja is a Director at Nayas Laboratories Private Limited (since 2022), Director at Sm Therapeutics Private Limited (since 2024) and Director at Jstl Pharmaceutical Private Limited (since 2022), and holds 3 more current directorships. The companies operate in Pharma, Professional Services and Real Estate and Construction. The largest current company by reported revenue is Nayas Laboratories Private Limited at ₹3.26 Cr (FY 2025). Earlier, Kuchipudi Vanaja was a Director at Jeevana Mitra Constructions Private Limited (1996–2019) and Director at Jeevan Scientific Technology Limited (1999–2020).

DIN 01030437
Primary Designation Director
Industry Pharma
First Appointment 01 Apr 1996
Oldest Company Age 7 yrs
Largest company Nayas Laboratories Private Limited · ₹3.26 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nayas Laboratories Private Limited U24290TG2022PTC167401
Director11 Oct 20222022₹3.26 Cr (FY 2025)Active
Sm Therapeutics Private Limited U72100TS2024PTC181179
Director18 Jan 20242024Active
Jstl Pharmaceutical Private Limited U24290TG2022PTC169293
Director15 Dec 20222022Active
Naya Pharma Private Limited U24100TG2020PTC142987
Director19 Aug 20202020Active
Jstl Pharma Llp AAT-2878
Designated Partner10 Aug 20202020Active
Designated Partner27 Aug 20192019Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Apr 19961987₹27.9 Lakh (FY 2019)Converted To Llp
Jeevan Scientific Technology Limited L72200TG1999PLC031016
Director02 Feb 19991999₹47.50 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Jeevana Mitra Constructions Llp
Jstl Pharma Llp
Naya Pharma Private Limited
Nayas Laboratories Private Limited
Premium access

Shareholding and investment profile for Kuchipudi Vanaja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kuchipudi Vanaja

Kuchipudi Vanaja currently holds 6 directorships: Nayas Laboratories Private Limited (Director, since 11 Oct 2022, revenue ₹3.26 Cr (FY 2025)); Sm Therapeutics Private Limited (Director, since 18 Jan 2024); Jstl Pharmaceutical Private Limited (Director, since 15 Dec 2022); Naya Pharma Private Limited (Director, since 19 Aug 2020); Jstl Pharma Llp (Designated Partner, since 10 Aug 2020); and 1 more.

Kuchipudi Vanaja was first appointed on 01 Apr 1996 as Director at Jeevana Mitra Constructions Private Limited. The most recent appointment on record is 18 Jan 2024 at Sm Therapeutics Private Limited.

Kuchipudi Vanaja held 2 earlier board appointments: Jeevana Mitra Constructions Private Limited (Director, 01 Apr 1996 to 26 Aug 2019); Jeevan Scientific Technology Limited (Director, 02 Feb 1999 to 02 Nov 2020).

The current boards of Kuchipudi Vanaja's companies include Jeevan Krishna Kuchipudi (Nayas Laboratories Private Limited), Koti Reddy Tiyyagura (Nayas Laboratories Private Limited), Krishna Kishore Kuchipudi (Nayas Laboratories Private Limited), Snigdha Mothukuri (Naya Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available